<DOC>
	<DOCNO>NCT00722436</DOCNO>
	<brief_summary>This randomize , blind , prospective study investigate potential benefit tranexamic acid reduce intraoperative bleeding blood transfusion pediatric patient undergo craniofacial surgery .</brief_summary>
	<brief_title>Tranexamic Acid Craniofacial Surgery</brief_title>
	<detailed_description>Surgical procedure correction craniofacial deformity result unavoidable significant blood loss small child infant . Patients may experience blood loss exceed one two blood volume . In effort reduce transfusion requirement , introduce tranexamic acid practice . However , benefit tranexamic acid pediatric craniofacial surgery yet report . We hypothesize intraoperative use tranexamic acid pediatric patient present craniofacial reconstruction reduce blood loss allogeneic transfusion requirement . This randomized , blind , prospective study investigate potential benefit tranexamic acid reduce intraoperative bleeding blood transfusion pediatric patient undergo craniofacial surgery . An initial dose 100 mg/kg tranexamic acid ( Cyclokapron 100mg/ml ) equal volume placebo administer 15 minute induction anesthesia skin incision . A maintenance infusion 10 mg/kg/hr tranexamic acid equal volume placebo start upon completion initial dose continue skin closure . The primary outcome include reduction total volume allogeneic erythrocyte .</detailed_description>
	<mesh_term>Craniosynostoses</mesh_term>
	<mesh_term>Tranexamic Acid</mesh_term>
	<criteria>The inclusion patient depend follow criterion : 1 . All pediatric patient schedule primary secondary repair craniosynostosis frontal orbital advancement , cranial vault reconstruction . 2 . Patients age 6 month 18 year old . 3 . They &gt; 5 kg . 4 . All subject evaluate Craniofacial Clinic primary secondary repair craniosynostosis potentially include study . Prior inclusion study potential participant screen history laboratory data . The laboratory data include complete blood count , PT , PTT , type cross , factor V leiden , anticardiolipin antibody , lupus anticoagulant . The history obtain parent current care taker . The medical record may review need clarification . Patients exclude study include follow : 1 . Familial personal coagulopathy riskfactor V leiden , anticardiolipin antibody , lupus anticoagulant 2 . Abnormal PT , PTT , Platelet count . closing time . All patient present craniofacial surgery preoperative blood work perform include type screen , HCT , PLT , PT , PTT , close time . Patients abnormality detect coagulation profile proceed complete hematologic evaluation include evaluation Von Willebrand 's Disease . 3 . History thrombotic episode patient 4 . Renal failure hepatic failure . 5 . Infants less 5 kg 6 . Age &lt; 6 month &gt; 18 year old</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>antifibrinolytic , tranexamic acid</keyword>
</DOC>